![Mario di Giacomo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Mario di Giacomo
Entité | Type d'entité | Industrie | |
---|---|---|---|
PharmaZell GmbH
![]() PharmaZell GmbH BiotechnologyHealth Technology PharmaZell GmbH engages in the development and provision of pharmaceutical active ingredients. It also offers services for formulation development and compiles required regulatory documents for both the originator and generic pharmaceutical industry. Its products include manufactured amino acids and controlled substances. The company was founded in 1946 and is headquartered in Raubling, Germany.
3
| Subsidiary | Biotechnology | 3 |
Farmabios SpA
![]() Farmabios SpA Pharmaceuticals: MajorHealth Technology Farmabios SpA engages in the manufacture and marketing of active ingredients for pharmaceutical applications. It offers oral cephalosporins, steroids hormones, highly potent substances, multipurpose plant for steroids, sterile cephalosporins, sterile steroids, and antineoplastics. The company was founded in 1961 and is headquartered in Gropello Cairoli, Italy.
2
| Subsidiary | Pharmaceuticals: Major | 2 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Mario di Giacomo via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
ZOOPLUS SE | Specialty Stores | Director/Board Member | |
INSEAD | College/University | Masters Business Admin | |
Ludwig-Maximilians-Universität München | College/University | Doctorate Degree | |
Novasep Holding SAS
![]() Novasep Holding SAS Chemicals: Major DiversifiedProcess Industries Novasep Holding SAS provides manufacturing solutions for the life science industries. Its products include agrochemicals fine chemicals and food ingredients. The company was founded by Roger-Marc Nicoud in 1995 and is headquartered in Lyon, France. | Chemicals: Major Diversified | Chief Executive Officer | |
Zellbios GmbH
![]() Zellbios GmbH Pharmaceuticals: MajorHealth Technology Part of PharmaZell GmbH, Zellbios GmbH is a German company that specializes in manufacturing cdmo solutions, supplying specialty api products, and producing anticancer drugs. Zellbios is based in Raubling, DE, and Sylke Hassel has been the CEO of the company since 2022. The company offers a wide range of reliable services for small molecule apis and biopharmaceuticals to innovators. Zellbios also supports innovative agrochemical companies with their apis for fungicides, insecticides, and herbicides in a safe and sustainable way. The company provides cdmo services for highly potent apis and cytotoxics and is an expert in pre-formulated nitroglycerin production. | Pharmaceuticals: Major | Chief Executive Officer | |
Maxburg Capital Partners GmbH
![]() Maxburg Capital Partners GmbH Investment ManagersFinance Maxburg Capital Partners GmbH (Maxburg Capital Partners) is a private equity firm founded in 2014 by Moritz Greve and Florian Seubert. The firm headquartered in Munich, Germany. | Investment Managers | Founder | |
ESCP Europe | College/University | Graduate Degree | |
Axplora
![]() Axplora Pharmaceuticals: OtherHealth Technology Axplora is a German company that focuses on delivering sustainable and technologically advanced API products and services. The private company is based in Raubling, Germany. The company's goal is to benefit people, patients, and the planet. The CEO of the company is Sylke Hassel. | Pharmaceuticals: Other | Chief Executive Officer |
Statistiques
Internationale
Allemagne | 7 |
France | 3 |
Sectorielle
Consumer Services | 4 |
Health Technology | 3 |
Retail Trade | 2 |
Process Industries | 2 |
Finance | 2 |
Opérationnelle
Chief Executive Officer | 5 |
Director/Board Member | 2 |
Compliance Officer | 1 |
Doctorate Degree | 1 |
Undergraduate Degree | 1 |
Relations les plus connectées
- Bourse
- Insiders
- Mario di Giacomo
- Connexions Sociétés